Ask the Expert

ASH 2020 Multiple Myeloma Daily Wrap-Up: New Treatments & Hope

Noopur Raje, MD, Faith Davies, MD, MBBCh, MRCP, FRCPath, Gareth Morgan, MD, PhD, FRCP, FRCPath, Andrew and Esther Schorr

What is Myeloma?

Paul Richardson, MD

New Drug Combinations for Treating Multiple Myeloma

James R. Berenson, MD, Andrew Schorr

Monoclonal Gammopathy of Undetermined Significance (MGUS)

James R. Berenson, MD, Andrew Schorr

Managing the Side Effects of Myeloma Treatment

Rafael Fonseca, MD, FACP, Andrew Schorr

How the BOSTON Study Impacts Myeloma Patients

Andrew Schorr, Paul Richardson, MD

COVID-19 Lessons for Myeloma Patients

Andrew Schorr, Rafael Fonseca, MD, FACP

Making Sense of New Myeloma Treatments During Coronavirus

Saad Z. Usmani, MD, FACP, Jack Aiello, Andrew Schorr

Myeloma Treatment Amid the Coronavirus Pandemic

Megan Trusdell, Robert Orlowski, MD, PhD

The Value and Phases of Multiple Myeloma Clinical Trials

Shebli Atrash, MD, Guido Tricot, MD, PhD, Frits van Rhee, MD, PhD, FACP, MRCP, FRCPath, Maddie Hunter

Update on Coronavirus Issues for Myeloma Patients

Faith Davies, MD, MBBCh, MRCP, FRCPath, Noopur Raje, MD

Myeloma Experts Discuss Coronavirus and Impact on Patient Care

Guido Tricot, MD, PhD, Frits van Rhee, MD, PhD, FACP, MRCP, FRCPath, Shebli Atrash, MD, Maddie Hunter

Cancer News Sent to You

Get e-Newsletters with the most current information about your health condition sent to your email!

Sign Up